IRCT20160523028008N27
Recruiting
Phase 2
Evaluation of efficacy of Topical Timolol for treatment in conjunctival Pyogenic Granuloma
Overview
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 46
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •Pyogenic granuloma
- •Consent to participate in the study
Exclusion Criteria
- •Presence of previous similar lesions
- •Lost of follow\-up after 6 week.
Investigators
Similar Trials
Completed
Phase 3
Topical Timolol Effectiveness for prophylaxy of radiation induced dermatitis in breast cancer patientsRadiodermatitis.Malignant neoplasm of breastIRCT20190810044500N11Yazd University of Medical Sciences64
Completed
Phase 2
Study Of Timolol Drops In Non Healing WoundsCTRI/2020/04/024754Dr Viral Chaitanya Bhatt100
Completed
Phase 1
To determine effectiveness of topical application of 0.5% Timolol Maleate in treatment of chronic heel recalcitrant fissuresIRCT20230712058759N1Pak Emirates Military Hospital150
Not yet recruiting
Not Applicable
To test the effectiveness of two commonly used medicines in Oral Lichen Planus and to study their molecular interactions.Health Condition 1: K00-K14- Diseases of oral cavity and salivary glandsCTRI/2023/08/056156MGM Dental College and Hospital
Recruiting
Phase 3
The efficacy and safety of 0.5% topical timolol on corneometry and transepidermal water loss after ablative fractional CO2 laser for atrophic acne scars: a split face randomized double blind placebo-controlled trialWe considered that timolol may have an effect in wound healing promotion in patients who undergo AFCO2 resurfacing. Our study aimed to investigate the efficacy and safety of 0.5% topical timolol maleaTCTR20190722005none25